Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Weight Watchers (WTW)’ Horrid Q1 Not Enough to Stop North Tide Capital From Double Digit Returns

Page 1 of 2

Conan Laughlin’s North Tide Capital posted impressive first quarter returns of 10.1% from its 14 long positions in companies valued at $1 billion or greater. With 25 long positions at the end of 2014, there were a number of unaccounted for positions in our estimated returns, as North Tide invested in nearly a dozen companies with market caps of less than $1 billion. However as with many funds, the majority of its top picks were in larger cap companies, with eight of its top ten picks have at least $1 billion market caps.

Even then, many of North Tide’s top picks are notable to us given the fact that they are in small-cap stocks (which we classify as having market caps between $1 billion and $5 billion). It’s investors like North Tide which add great value to our small-cap strategy system, as they are heavily invested in the success of their small-cap picks and have poured considerable resources into identifying undervalued or under-the-radar companies to invest in. We have found that collectively, hedge funds’ top small-cap picks provide a great investment opportunity, with our strategy having returned over 137% since it was launched at the end of August, 2012 and beating the market by more than 80 percentage points (see the details).

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is one of the largest companies North Tide is invested in, as it held a 3.0 million share position valued at $172.53 million in the $70 billion pharmaceutical company. That position was North Tide’s second-largest, and accounted for 11.59% of its equity portfolio.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares were up by 8.97% during the first quarter, which was good news for George Soros and a number of other billionaire investors who are crazy about Teva. All told, ten billionaires had positions in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) at the start of 2015, with $799 million of their formidable wealth invested in it.

A position in Kindred Healthcare, Inc. (NYSE:KND) was North Tide’s fourth-largest, and was increased by 54% during the fourth quarter. That added investment paid off in a big way, as shares of Kindred Healthcare, Inc. (NYSE:KND) ballooned by 31.58% during the first quarter. The $2 billion market cap provider of healthcare living and rehabilitation facilities also helped billionaire Steve Cohen trump the market in the first quarter, though he had much less exposure to the stock than North Tide. Laughlin’s fund in fact had the highest exposure of any fund in our database, in addition to owning the largest position at 5.0 million shares valued at $90.90 million.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!